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Abstract Phagocytosis of IgG-opsonized participate material 
in hematopoietic cells is mediated by Fey receptors (FcyRs). 
Interaction of the receptors with Fc domains of IgG triggers 
transduction of phagocytic signal in which a key role is played by 
phosphorylation of tyrosine residues of the receptors. These 
residues are arranged into a specific motif (immunoreceptor 
tyrosine-based activation motif; ITAM) which is located either 
in the cytoplasmic part of FeyRIIA or in γchains associated with 
FeyRI and FcyRIIIA. The conserved tyrosine residues are 
phosphorylated by, and associate with, tyrosine kinases of Src 
and Syk families. Coordinated action of these components 
initiates numerous intracellular events leading finally to local 
rearrangement of the actin-based cytoskeleton and internaliza-
tion of the particles. 
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1. Introduction 
Several receptors that mediate binding and ingestión of 
particulate material have been identified in hematopoietic 
cells. These receptors may interact either directly with the 
particles recognizing determinants present on their surface 
or may bind to opsonins coating the particles. FcyRs are 
the opsonin-dependent membrane constituents which recog-
nize the Fc domain of opsonin IgG. This interaction triggers 
a variety of responses, among them actin-dependent interna-
lization of the particles. Being engaged in phagocytosis of 
IgG-coated targets (e.g. microorganisms) FcyRs play a crucial 
role in the immune defence system. Various aspects of FcyR 
structure and function have been considered previously [1-3]. 
In this review, we focus on the role of tyrosine phosphoryla-
tion in regulation of FcyR-mediated phagocytosis. 
2. Fey receptors 
Three distinct classes of FcyRs have been identified: FcyRI, 
FcyRII and FcyRIII. They are members of the Ig gene super-
family and share a highly homologous extracellular portion 
which contains the IgG binding domain; however, there are 
some differences in the receptors' structure. FcyRII is a mono-
mer while FcyRI and FcyRIII exist as oligomeric complexes in 
which the a chain, bearing the IgG binding domain, associ-
ates with dimers composed of homologous, disulphide-linked, 
y and ζ chains [1]. The oc chain of FcyRIII interacts with y and 
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ζ homo- and heterodimers [4,5]. In the case of FcyRI only the 
y accessory chain has been identified [6]. 
FcyRI (a chain; a 72 kDa sialoglycoprotein) binds mono-
meric IgG with high affinity and is expressed on monocytes, 
macrophages and interferon-γ stimulated neutrophils. FcyRII 
(a 40 kDa sialoglycoprotein) is a low-affinity receptor which 
preferentially binds to multivalent ligands. Its several isoforms 
originate from the expression of three genes: FeyRIIA, B, C 
and alternative splicing of FcyRIIB (FcyRIIBl and FcyRIIB2) 
and have different distribution in hematopoietic cells [7,8]. 
FeyRIIA occurs mainly in phagocytic cells (monocytes, 
macrophages and granulocytes) and is the only FcyR identi-
fied in platelets. FcyRIIB is preferentially expressed in B- and 
T-cells. FcyRIIC is the result of unequal cross-over between 
FcyRIIB and FeyRIIA that contains the extracellular and 
transmembrane portion of FcyRIIB and the FeyRIIA tail 
[9]. It is present in neutrophils, monocytes and B-cells. 
FcyRIII is also a low-affinity receptor with the molecular 
mass of the a chain ranging from 51 to 73 kDa. It is encoded 
by two genes: FcyRIIIA and B. FcyRIIIA is expressed as a 
transmembrane form on NK cells and macrophages. 
FcyRIIIB is a glycosylphosphatidyhnositol-linked receptor 
lacking transmembrane and cytoplasmic domains, and may 
mediate the phagocytic signal in cooperation with other re-
ceptors. It is expressed solely in neutrophils [10,11]. 
During activation of FcyRs, upon onset of phagocytosis or 
by cross-linking of the receptors with specific antibodies, tyr-
osine residues in the cytoplasmic parts of the receptors be-
come phosphorylated [12-15]. The tyrosines are located within 
a common motif forming a minimal functional segment of the 
receptors [16]. The motif consists of paired tyrosines and leu-
cines in the consensus sequence YxxL(x)7/12YxxL, and is re-
ferred to as the immunoreceptor tyrosine-based activation 
motif (ITAM). The role of ITAM in transduction of phago-
cytic signal was elucidated using several model systems, 
among which COS cells, lacking endogenous FcyRs and trans-
fected with various constructs of human receptors, were espe-
cially useful. COS cells transfected with FeyRIIA ingest IgG-
sensitized particles [17]. Transfection of a human FeyRIIA 
cDNA induces also T-cells to become phagocytic [18]. The 
cytoplasmic domain of FeyRIIA contains two YxxL se-
quences (Y282 and Y298) arranged into an ITAM motif 
plus an additional tyrosine residue at position 275. Further 
studies showed that deletion of Y282 or Y298 from ITAM 
inhibited phagocytosis by 50 to 65%, but replacement of Y275 
did not affect phagocytosis. These data indicate that at least 
two cytoplasmic tyrosines, including the typical single YxxL 
motif, are required for phagocytosis mediated by this recep-
tor. It was proposed that Y275 plays a 'back-up' function 
when one tyrosine residue of ITAM is missing [19]. FcyRIIB 
has only a single YxxL sequence. In the human FcyRIIBl 
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Fig. 1. Scheme of initial events induced after Fey receptors stimulation in phagocytic cells. (A) Resting cell; (B) cell with activated Fey recep-
tors. For detailed description, see text. 
isoform the YxxL sequence comprises Y292 while in the 
FcyRIIB2 isoform this sequence starts at Y273 [20]. COS cells 
transfectants expressing either FcyRIIBl or FcyRIIB2 or mu-
tated FcyRIIA lacking the cytoplasmic tail, efficiently bind 
particles but do not ingest them. The phagocytic incompe-
tence of these cells was attributed to a lack of phosphoryla-
tion of the expressed receptor isoforms. The phagocytic activ-
ity of the non-phagocytic FcyRIIB2 was partially restored by 
insertion of the YxxL sequence upstream of the original one, 
which resulted in formation of a sequence resembling ITAM 
of FcyRIIA. The activity was additionally improved by intro-
duction of the tyrosine residue downstream of the motif giving 
a final combination of three tyrosine residues arranged into 
two ITAM-related configurations [21]. The a chains of FcyRI 
and FcyRIIIA do not possess tyrosine residues and these re-
ceptors transmit a phagocytic signal through associated γ 
chains bearing one intact ITAM motif [22-24]. The ζ chain 
which contains multiple copies of ITAM is less efficient in 
induction of phagocytosis than the γ chain [25,26]. Interest-
ingly, ζ-associated isoforms of FcyRIIIA are confined to NK-
cells and seem to be specialized to accompany cytotoxic activ-
ity of these cells [4]. 
These studies point to the importance of the ITAM motif 
for FcyR-mediated phagocytosis. It is believed that the con-
served tyrosine residues of FcyRs serve as substrates for in-
tracellular tyrosine kinases and subsequently as docking sites 
for SH2 domain(s) of the kinases. 
3. Fey-associated tyrosine kinases 
Two classes of protein tyrosine kinases, members of the Src 
and Syk families, have been implicated in the function of the 
FcyRs. 
So far, five out of nine members of the Src gene family 
kinases have been identified in phagocytic cells: Src, Fyn, 
Fgr, Hck, Lyn [27]. The conserved region of the Src family 
kinases can be divided into five domains: the extreme N-ter-
minal domain contains myristoylated glycine which is respon-
sible for membrane association; the src homology SH3 and 
SH2 regions; the catalytic domain and the C-terminal non-
catalytic tail. Within the tail a tyrosine residue is located (e.g. 
Y527 in Src) which, when phosphorylated, inhibits catalytic 
activity of the kinases. It is commonly accepted that this 
phosphorylated tyrosine interacts intramolecularly with the 
SH2 domain of its own kinase, which results in the formation 
of an inactive enzyme (for review see [28,29]) (Fig. 1A). The 
negative regulation of Src family kinase activity is probably 
the result of phosphorylation by Csk which is capable of 
phosphorylating the C-terminal tyrosine residue of Src, Lyn 
and Fyn [30,31]. Dephosphorylation of this tyrosine residue 
exposes the SH2 domain which can then bind to the phospho-
tyrosine residue in the activated receptor (Fig. IB). However, 
activation of members of the Src family may also be induced 
by (auto)phosphorylation of another tyrosine residue (Y416) 
identified within the catalytic domain of Src [28]. Src, and to a 
lesser extent Lyn and Fyn, phosphorylate FcyRIIA in vitro 
suggesting a possible function of the kinases in vivo [32,33]. In 
accordance with this supposition, Src-deficient cells are less 
capable of FcyRIIA-mediated phagocytosis and receptor 
phosphorylation [33]. In neutrophils FcyRII is associated 
with Fgr and the receptor cross-linking is accompanied by 
Fgr activation [34]. FcyRI and FcyRII in monocytic cells are 
physically and functionally associated with two other Src fam-
ily kinases - Hck and Lyn. Furthermore, activation of the 
receptors is followed by tyrosine phosphorylation of Hck and 
Lyn and an increase in these kinases' activity, thus resembling 
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the FcyRII-Fgr interaction [35,36]. Members of the Src family 
kinases are implicated in the very early stages of phagocytic 
signal transduction although the details of the FcyR-kinase 
interaction, regulated probably in a cell-specific manner, are 
unknown [32,35,37]. 
Syk and closely related ZAP-70 kinases are not myristoy-
lated and hence are not constitutively bound to the plasma 
membrane. They bear two N-terminal SH2 domains and a C-
terminal catalytic domain. Syk (72 kDa) is expressed in all 
hematopoietic cells, whereas ZAP-70 (70 kDa) occurs exclu-
sively in T- and NK-cells [38,39]. Several lines of evidence 
point to interaction of Syk with FcyRI and FcyRIIIA which 
is mediated by the γ chain of the receptors: (i) in macro-
phages, the enzymatic activity of Syk is enhanced and tyrosine 
residues of the kinase are phosphorylated upon activation of 
FcyRIIIA [15,37]; (ii) Syk coimmunoprecipitates with the γ 
chain of FcyRIIIA in these cells [37]; (iii) based on similar 
data: kinase hyperphosphorylation and activation after FcyRI 
cross-linking as well as coimmunoprecipitation with γ chain of 
the receptor, Syk is thought to be involved in signal transduc-
tion through the FcyRI in monocytes [14,40]; (iv) cotransfec-
tion of Syk with the y chain and FcyRI or FcyRIIIA markedly 
enhanced the phagocytic capability of COS cells compared to 
that of FcyRI/y or FcyRIIA/y transfectants. Due to require-
ment of the presence of both tyrosine residues in the ITAM 
motif of the y chain for the action of Syk, it is proposed that 
Syk binds to, via its two SH2 domains, and is activated by 
tyrosine phosphorylated ITAMs [24] (Fig. IB); (v) confirming 
the last suggestion, Syk was identified as a necessary compo-
nent acting downstream of y chains in the pathway leading 
from ITAM activation to actin assembly [41]. In contrast to 
Syk, ZAP-70 kinase required additionally participation of Fyn 
kinase to enhance phagocytosis in COS cells transfected with 
FcyRIIIA and the y (or ζ) chain [26]. These data suggest 
possible cooperation between the Syk and Src tyrosine kinase 
families. The function of Syk is less clear in the case of 
FcyRIIA which does not associate with the y chain and is 
able to retain partial phagocytic ability with one tyrosine re-
sidue of ITAM missing [19]. However, since cross-linking of 
FcyRII induces phosphorylation and activation of Syk, it 
seems possible that Syk is also involved in phagocytosis 
mediated by this receptor [12,40,42]. Recent studies on chi-
meric proteins composed of the extracellular domain of 
FcyRIII connected to various tyrosine kinases indicated the 
importance of Syk kinases for Fcy-mediated phagocytosis 
when the chimeric proteins were transfected into COS cells. 
Only Syk, and to a lesser extent ZAP-70 transfectants gained 
phagocytic abilities, provided the enzymatic activity of the 
kinase was preserved [43]. 
The involvement of protein tyrosine kinases in FcyR-
mediated signalling events was confirmed by using inhibitors 
of the kinases. Genistein, tyrphostin 23, erbstatin, or herbi-
mycin-A block both phagocytosis and phosphorylation of nu-
merous proteins involved in these events, as has been demon-
strated in monocytes, macrophages and COS cell transfectants 
[5,13,23,25,44,45]. In neutrophils, however, neither genistein 
nor erbstatin reduced FcyR-mediated phagocytosis of particu-
late material although they almost completely inhibited tyro-
sine phosphorylation of FcyRII. It has been suggested that, in 
neutrophils, the phosphorylation of FcyRII is a process not 
directly involved in phagocytosis but rather in other cell re-
sponses associated with phagocytosis [46]. 
13 
4. Substrates of tyrosine kinases 
Activation of FcyRs induces rapid and transient tyrosine 
phosphorylation of various cytoplasmic and membrane pro-
teins including FcyRII and y subunits of FcyRI and FcyRIIIA 
[12,13,15,37,40,44,45]. Some of the other phosphotyrosine-
containing proteins have been identified, e.g. paxilin (68 
kDa), a cytoskeleton-associated, Src tyrosine kinase substrate 
which colocalizes with F-actin beneath nascent phagosomes 
[15,31]. The tyrosine phosphorylated proteins of 50-60 kDa 
are likely to belong to the Src family kinases [34-36]. The 
polypeptide of 72 kDa has been suggested to be Syk kinase 
[12,15,37,40,42]. 
Another phosphorylated polypeptide (115 kDa) is known to 
be associated with PI3-kinase (PI3-K), presumably by binding 
to the SH2 domain of p85, a regulatory subunit of the en-
zyme. The activity of PI3-K increases after FcyR stimulation 
[47]. The importance of PI3-K for FcyR-mediated phagocyto-
sis was confirmed by studies using wortmanin, a specific PI3-
K inhibitor, which blocks phagocytosis in monocytes, neutro-
phils as well as in COS cells transfected with either of the 
three classes of FcyRs [2,47]. In COS transfectants PI3-K 
coimmunoprecipitated with Syk kinase after FcyRI cross-link-
ing which indicates that the kinases may form a complex [2]. 
Phospholipase C (PLC) yl and PLCy2 also belong to the 
proteins phosphorylated on tyrosine upon FcyR activation. 
Being phosphorylated PLCyl causes hydrolysis of PIP2 and 
intracellular calcium mobilization [12,48]. Nevertheless, sev-
eral data contradict any involvement of PLCy and calcium 
ions in FcyR-mediated phagocytosis suggesting, however, 
their participation in some phagocytosis-related events ([3] 
and references therein). 
Proteins of the Ras signalling pathway form another group 
of polypeptides found to be phosphorylated during FcyR ac-
tivation. This group includes p95Vav, p62/GAP-associated 
protein and p21Ras-GAP [12,37]. 
Many of the cellular responses discussed above are similar 
to the cascade of events generated by B- and T-cell receptors, 
the cytoplasmic domains of which also contain a homologous 
signalling motif ITAM (for review see [49]). 
5. Signal generation 
On the basis of the data discussed above the following 
scheme of initial events of the FcyR-mediated phagocytosis 
can be proposed (Fig. 1). In non-stimulated cells Csk phos-
phorylates the C-terminal tyrosine residue of Src kinases (e.g. 
Y527 in Src). The phosphorylated tyrosine binds intramolecu-
larly its own SH2 domain, making the enzyme inactive (Fig. 
1A). In stimulated cells, binding of particulate ligands to the 
extracellular domains of FcyRs causes clustering of the recep-
tors (Fig. IB). Under these conditions Src kinase is activated 
by dephosphorylation of the C-terminal tyrosine residue. In 
this process CD45, a tyrosine phosphatase of hematopoietic 
cells, may be engaged, as it was found to dephosphorylate and 
activate the Src family kinases in T-cells [49]. Co-cross-linking 
of CD45 and FcyRs inhibits overall tyrosine phosphorylation, 
which follows the receptor activation, and blocks some of the 
downstream tyrosine kinase-dependent events, supporting this 
possibility [12,44]. Activation of the Src family kinases is ad-
ditionally enhanced by phosphorylation of another tyrosine 
residue located within the catalytic domain (e.g. Y416 in 
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Src). The activated Src phosphorylates tyrosine residues with-
in the ITAM motif of FcyRs. Phosphorylated tyrosines in 
ITAM serve as high-affinity binding sites for SH2 domains 
of Src and Syk kinases. Syk phosphorylates a putative p85-
binding protein (p85bp), which may serve as a specific dock-
ing molecule for the SH2 domain of p85, a regulatory subunit 
of PI3-K. Reciprocal interactions between phosphorylated 
tyrosine residues and SH2 domains of Syk and PI3-K kinases 
are also possible [50]. Additionally, PI3-K may bind to the 
SH3 domain of Src family kinases [51]. The pi 10 subunit of 
PI3-K catalyses formation of phosphorylated phosphoinosi-
tides such as PIP3 which binds to a putative PIP3-binding 
protein (PIP3bp). PIP3 as well as GAP, Grb2/Sos and Vav 
directly or indirectly, by Rac or Ras may promote actin poly-
merization [37]. The local actin filament assembly is believed 
to be an essential step in internalization of particulate materi-
al. 
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